Listed

Lineage Cell Therapeutics, Inc.: Form 8-K, filed May 12, 2022

Filed with the SEC on May 12, 2022 and accepted by EDGAR at May 11, 2022, 19:54 ET.

Share

Items reported

  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events
  • Item 9.01 Financial statements and exhibits

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001493152-22-012893. Last ingested by Listed: Nov 13, 2026, 16:09 ET. Listed shows no prices and gives no investment advice.